Bilateral diaphragmatic palsy following Nivolumab–Ipilimumab therapy: A rare respiratory complication of immune checkpoint inhibitors

Vikas Marwah, Narayanan Subramanian, Sharanpreet Kaur Aulakh, Suresh Pandalanghat, Prafull Sharma

Open source

DOI
10.4103/lungindia.lungindia_38_26
Published
2026-06-24
Container
Lung India
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4103/lungindia.lungindia_38_26,
  title = {Bilateral diaphragmatic palsy following Nivolumab–Ipilimumab therapy: A rare respiratory complication of immune checkpoint inhibitors},
  author = {Vikas Marwah and Narayanan Subramanian and Sharanpreet Kaur Aulakh and Suresh Pandalanghat and Prafull Sharma},
  year = {2026},
  journal = {Lung India},
  doi = {10.4103/lungindia.lungindia_38_26},
  url = {https://doi.org/10.4103/lungindia.lungindia_38_26}
}

RIS

TY  - JOUR
TI  - Bilateral diaphragmatic palsy following Nivolumab–Ipilimumab therapy: A rare respiratory complication of immune checkpoint inhibitors
AU  - Vikas Marwah
AU  - Narayanan Subramanian
AU  - Sharanpreet Kaur Aulakh
AU  - Suresh Pandalanghat
AU  - Prafull Sharma
PY  - 2026
JO  - Lung India
DO  - 10.4103/lungindia.lungindia_38_26
UR  - https://doi.org/10.4103/lungindia.lungindia_38_26
ER  - 

APA

Marwah, V., Subramanian, N., Aulakh, S. K., Pandalanghat, S., & Sharma, P. (2026). Bilateral diaphragmatic palsy following Nivolumab–Ipilimumab therapy: A rare respiratory complication of immune checkpoint inhibitors. Lung India. https://doi.org/10.4103/lungindia.lungindia_38_26

Source records